0001518957-14-000003.txt : 20140507 0001518957-14-000003.hdr.sgml : 20140507 20140507090356 ACCESSION NUMBER: 0001518957-14-000003 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20140507 DATE AS OF CHANGE: 20140507 EFFECTIVENESS DATE: 20140507 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Enumeral Biomedical Corp. CENTRAL INDEX KEY: 0001518957 IRS NUMBER: 271509860 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-216918 FILM NUMBER: 14819016 BUSINESS ADDRESS: STREET 1: 1450 BROADWAY, 24TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10018 BUSINESS PHONE: 347-277-4787 MAIL ADDRESS: STREET 1: 1450 BROADWAY, 24TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10018 D 1 primary_doc.xml X0707 D LIVE 0001518957 Enumeral Biomedical Corp. 1450 BROADWAY, 24TH FLOOR NEW YORK NY NEW YORK 10018 347-277-4787 DELAWARE Enumeral Technologies, Inc. None Corporation true 2009 Arthur H. Tinkelenberg c/o Enumeral Biomedical Corp. 1450 Broadway, 24th Floor New York NY NEW YORK 10018 Executive Officer Director Barry Buckland c/o Enumeral Biomedical Corp. 1450 Broadway, 24th Floor New York NY NEW YORK 10018 Director Emanuele Ostuni c/o Enumeral Biomedical Corp. 1450 Broadway, 24th Floor New York NY NEW YORK 10018 Director John Rydzewski c/o Enumeral Biomedical Corp. 1450 Broadway, 24th Floor New York NY NEW YORK 10018 Executive Officer Director Michael Weiss c/o Enumeral Biomedical Corp. 1450 Broadway, 24th Floor New York NY NEW YORK 10018 Director Daniel Wolfe c/o Enumeral Biomedical Corp. 1450 Broadway, 24th Floor New York NY NEW YORK 10018 Director Derek Brand c/o Enumeral Biomedical Corp. 1450 Broadway, 24th Floor New York NY NEW YORK 10018 Executive Officer Allan Rothstein c/o Enumeral Biomedical Corp. 1450 Broadway, 24th Floor New York NY NEW YORK 10018 Director Biotechnology Decline to Disclose 06b false 2014-04-25 false true false 0 BlackBook Capital LLC 123234 None None 420 Lexington Avenue New York NY NEW YORK 10170 AL ALABAMA IL ILLINOIS KY KENTUCKY LA LOUISIANA MS MISSISSIPPI NY NEW YORK OH OHIO PA PENNSYLVANIA TX TEXAS false Indefinite 2016250 Indefinite false 5 81300 0 $81,300 in sales commission and warrants with a term of 5 years for approximately 38,258 Series B shares with an exercise price of $2.125 0 false Enumeral Biomedical Corp. Arthur H. Tinkelenberg Arthur H. Tinkelenberg President 2014-05-07